Effects of Epigallocatechin Gallate (EGCG) in Healthy, Young Adults
Launched by NORTHUMBRIA UNIVERSITY · Sep 21, 2009
Trial Information
Current as of May 14, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • healthy
- • aged 18-35
- • either caffeine consumers (consume more than 150mg caffeine per day) or non-consumers (consume less than 44mg caffeine per day).
- Exclusion Criteria:
- • smoke or consume any tobacco products
- • not proficient in English language
- • pregnant (or seeking to become pregnant)
- • taking recreational, over the counter/prescription medication (including the contraceptive pill), and/or dietary/herbal supplements
- • have food allergies or sensitivities
- • have history of/current head trauma, learning difficulties , ADHD, migraines or any gastric problems
About Northumbria University
Northumbria University is a leading research-intensive institution based in the UK, dedicated to advancing knowledge and innovation in various fields, including health sciences. As a clinical trial sponsor, the university leverages its academic expertise and state-of-the-art facilities to conduct high-quality research aimed at improving patient outcomes and informing clinical practices. With a commitment to ethical standards and regulatory compliance, Northumbria University collaborates with healthcare professionals and industry partners to explore novel therapeutic interventions and contribute to the body of evidence that shapes modern medicine.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Newcastle Upon Tyne, , United Kingdom
Patients applied
Trial Officials
Crystal Haskell
Principal Investigator
Northumbria University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials